Interleukin-2 and lymphokine-activated killer cell therapy for gastrointestinal cancer.
Guillou
P
P
Adacemic Surgical Unit, St Mary's Hospital Medical School, London, UK.
D005770:Gastrointestinal Neoplasms / Q000628:therapy*; D006801:Humans; D007116:Immunization, Passive; D007167:Immunotherapy; D007376:Interleukin-2 / Q000276:immunology / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000637:transplantation*; D008222:Lymphokines / Q000276:immunology
D007376:Interleukin-2; D008222:Lymphokines